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We present a case of a 64-year-old woman showing multistep progression from adenoma to adeno-
carcinoma in the bladder 46 years after augmentation ileocystoplasty. She underwent augmentation
ileocystoplasty for tuberculous contracted bladder at 18 years. After 44 years, tubulovillous adenomas
were found and resected at the ileovesical anastomosis site. After 2 more years, bladder tumors recurred
and revealed adenocarcinomas. Finally, radical cystectomy was required because of frequent recurrence
and tumor extensiveness. To our knowledge, this is the ﬁrst case demonstrating adenoma-carcinoma
sequence histopathologically in the bladder after augmentation cystoplasty, indicating multistep carci-
nogenesis similar to intestinal carcinogenesis.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Augmentation cystoplasty using an intestinal tract is
indicated for patients with a deterioration of bladder storage
function resistant to pharmacologic or other conservative in-
terventions. For example, patients with neurogenic bladder
caused by spinal cord injury, contracted bladder caused by uro-
genital tuberculosis, or interstitial cystitis are candidates for
augmentation cystoplasty. Malignant transformation of primary
or substitutional bladder epithelium after augmentation cys-
toplasty is rare and needs a long postoperative period.1 However,
these malignant tumors are frequently aggressive and associated
with a poor prognosis,2 and the mechanisms of carcinogenesis
are unclear.
We previously reported a case of a 62-year-old woman with
tubulovillous adenoma that developed 44 years after ileocystoplasty.3
Two more years later, she developed bladder adenocarcinoma. The
adenoma-carcinoma sequence has been implicated in the multistep
processes of intestinal carcinogenesis in colon cancer.4 To the best of
our knowledge, this is the ﬁrst case report to provide histopathologic
evidence of the adenoma-carcinoma sequence in the bladder after
augmentation cystoplasty.BY-NC-ND license (http://
: þ81-3-5800-8917.
i).
Published by Elsevier Inc. All righCase presentation
A 16-year-old female patient underwent right nephrectomy for
renal tuberculosis. Augmentation ileocystoplasty for tuberculosis
contracted bladder was performed at 18 years. Left nephrostomy
was required at 38 years because of hydronephrosis and repeated
pyelonephritis.
In March 2005, 44 years after ileocystoplasty, the patient pre-
sented at our hospital with gross hematuria. Cystoscopy revealed
multiple papillary tumors in the region of the ileovesical anasto-
mosis. Transurethral resection of the bladder tumor (TURBT) was
performed. Histopathologic examination revealed tubulovillous
adenoma (Fig. 1A). The tumor recurred 4 times, necessitating
repeated TURBT in April 2005, November 2007, March 2008, and
October 2008. Histopathologic diagnosis was tubulovillous ade-
noma at the second TURBT in 2005, but the diagnosis of well-
differentiated adenocarcinoma, pTa, (Fig. 1B) was made at the
third TURBT in 2007, 46 years after ileocystoplasty. The fourth and
ﬁfth TURBT also revealed well-differentiated adenocarcinoma.
In January 2009, radical cystectomy with ileal conduit diversion
was performed because of incomplete resection during the ﬁfth
TURBT. Macroscopic ﬁndings (Fig. 2A) and histologic examination
(Fig. 2B) revealed that the tumor developed around the region of
ileovesical anastomosis. Histopathologic diagnosis was well-
differentiated adenocarcinoma, pTa, u-rt0, u-lt0, ur0, ew0, ly0, v0,
pN0 (Fig. 2B). The postoperative course was uneventful, and the left
nephrostomy catheter was removed. She has been recurrence and
metastasis free until December 2013.ts reserved.
Figure 1. Histopathologic ﬁndings showing adenoma-carcinoma sequence (hematoxylin and eosin stain). (A) Tubulovillous adenoma identiﬁed during the ﬁrst transurethral
resection of the bladder tumor in 2005. Cells with minimum nuclear atypicality formed in glandular and villiform structure. (B) Well-differentiated adenocarcinoma identiﬁed
during the third transurethral resection of the bladder tumor in 2007. Atypical tumor cells formed in the glandular structure. Tumor stage was pTa. Scale bars represent 50 mm.
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Malignant transformation of primary or substitutional bladder
epithelium is relatively rare, with an approximate risk of 1.2% in
patients treated with augmentation cystoplasty.1 Malignant tu-
mors may develop over long periods, usually more than 10 years,
in augmented bladders.1 However, these malignant tumors are
frequently aggressive and cause the death in nearly 50% of
patients.2
Bladder tumors after augmentation cystoplasty are generally
adenocarcinoma most commonly located in the region of enter-
ovesical anastomosis,5 in which urothelial cells at the site of the
anastomosis may be susceptible to intestinal metaplasia. Previous
reports have shown that urothelial cells at the enterovesical
junction acquire characteristic of the enteric epithelium in an
experimental canine model of augmentation cystoplasty.6
Furthermore, a variety of gene aberrations have been found in
the region of enterovesical anastomosis in patients treated with
ileocystoplasty, such as chromosomal numerical abnormalities in
chromosomes 18, 9, and 8,7 and p53 mutations.8 These ﬁndings
suggest that multiple factors are involved in the bladder carcino-
genesis after cystoplasty.Figure 2. Macroscopic and histopathologic ﬁndings after total cystectomy. (A)
Macroscopic ﬁndings of the isolated preparation. Multiple tumors (arrowheads) were
found in the region of the anastomosis (broken line) of primary bladder (black arrow)
and substituted bladder by the ileal segment (white arrow). Scale bars represent 1 cm.
(B) Histopathologic ﬁndings (hematoxylin and eosin stain). The tumor (arrowheads)
was located around the site of anastomosis (broken line) of primary bladder (black
arrow) and in the ileal segment (white arrow). Histopathologic diagnosis was well-
differentiated adenocarcinoma, pTa, u-rt0, u-lt0, ur0, ew0, ly0, v0, pN0. Scale bars
represent 1 mm.Intestinal carcinogenesis is known to be a multistep process
called adenoma-carcinoma sequence, progressing from adenoma
to adenocarcinoma, involving various oncogenic factors.4 Our case
newly demonstrated adenoma-carcinoma sequence histopatho-
logically in the bladder after augmentation cystoplasty. Our ﬁnd-
ings suggest that multistep carcinogenesis develops in the region
of enterovesical anastomosis after cystoplasty as the intestinal
carcinogenesis.
Late diagnosis of the diseases at an advanced stage accounts for
the poor prognosis of patients with malignancies after cystoplasty.2
In our case, the malignancy was fortunately discovered at the stage
of tubulovillous adenoma, and a good prognosis was achieved. Our
experience in the current case suggests that detection at the early
stage of carcinogenesis improves patient prognosis in malignancies
after augmentation cystoplasty.Conclusion
Carcinogenesis in the bladder after augmentation cystoplasty
may be a multistep process, progressing adenoma to adenocarci-
noma, and detection at the early stage of carcinogenesis would be
important for patient prognosis.Conﬂict of interest
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